Literature DB >> 18353950

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

J H C M Kreijtz1, G de Mutsert, C A van Baalen, R A M Fouchier, A D M E Osterhaus, G F Rimmelzwaan.   

Abstract

Since the number of human cases of infection with avian H5N1 influenza viruses is ever increasing, a pandemic outbreak caused by these viruses is feared. Therefore, in addition to virus-specific antibodies, there is considerable interest in immune correlates of protection against these viruses, which could be a target for the development of more universal vaccines. After infection with seasonal influenza A viruses of the H3N2 and H1N1 subtypes, individuals develop virus-specific cytotoxic T-lymphocyte responses, which are mainly directed against the relatively conserved internal proteins of the virus, like the nucleoprotein (NP). Virus-specific cytotoxic T lymphocytes (CTL) are known to contribute to protective immunity against infection, but knowledge about the extent of cross-reactivity with avian H5N1 influenza viruses is sparse. In the present study, we evaluated the cross-reactivity with H5N1 influenza viruses of polyclonal CTL obtained from a group of well-defined HLA-typed study subjects. To this end, the recognition of synthetic peptides representing H5N1 analogues of known CTL epitopes was studied. In addition, the ability of CTL specific for seasonal H3N2 influenza virus to recognize the NP of H5N1 influenza virus or H5N1 virus-infected cells was tested. It was concluded that, apart from some individual epitopes that displayed amino acid variation between H3N2 and H5N1 influenza viruses, considerable cross-reactivity exists with H5N1 viruses. This preexisting cross-reactive T-cell immunity in the human population may dampen the impact of a next pandemic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353950      PMCID: PMC2395172          DOI: 10.1128/JVI.02694-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Host species barriers to influenza virus infections.

Authors:  Thijs Kuiken; Edward C Holmes; John McCauley; Guus F Rimmelzwaan; Catherine S Williams; Bryan T Grenfell
Journal:  Science       Date:  2006-04-21       Impact factor: 47.728

2.  Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

Authors:  Suzanne L Epstein
Journal:  J Infect Dis       Date:  2005-11-21       Impact factor: 5.226

3.  Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.

Authors:  E C Claas; A D Osterhaus; R van Beek; J C De Jong; G F Rimmelzwaan; D A Senne; S Krauss; K F Shortridge; R G Webster
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

4.  Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.

Authors:  Carel A van Baalen; David Kwa; Esther J Verschuren; Mariska L Reedijk; Adrianus C M Boon; Gerrie de Mutsert; Guus F Rimmelzwaan; Albert D M E Osterhaus; Rob A Gruters
Journal:  J Infect Dis       Date:  2005-08-30       Impact factor: 5.226

5.  Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species.

Authors:  J Jameson; J Cruz; M Terajima; F A Ennis
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

6.  Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

Authors:  J H C M Kreijtz; R Bodewes; G van Amerongen; T Kuiken; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Vaccine       Date:  2006-09-07       Impact factor: 3.641

7.  Virus-specific CD8+ T cells in primary and secondary influenza pneumonia.

Authors:  K J Flynn; G T Belz; J D Altman; R Ahmed; D L Woodland; P C Doherty
Journal:  Immunity       Date:  1998-06       Impact factor: 31.745

8.  Human cytotoxic T-lymphocyte repertoire to influenza A viruses.

Authors:  J Jameson; J Cruz; F A Ennis
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

Authors:  Matthew R Sandbulte; Gretchen S Jimenez; Adrianus C M Boon; Larry R Smith; John J Treanor; Richard J Webby
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

Review 10.  Avian influenza A (H5N1) age distribution in humans.

Authors:  Matthew Smallman-Raynor; Andrew D Cliff
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more
  111 in total

1.  Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.

Authors:  Megan K L MacLeod; Amy S McKee; Alexandria David; Jieru Wang; Robert Mason; John W Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  CD4+ T cells limit the damage in influenza.

Authors:  Anne Kelso
Journal:  Nat Med       Date:  2012-02-06       Impact factor: 53.440

3.  Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus.

Authors:  Alina C Boesteanu; Nadarajan S Babu; Margaret Wheatley; Elisabeth S Papazoglou; Peter D Katsikis
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

4.  Location of antigenic sites recognized by monoclonal antibodies in the influenza A virus nucleoprotein molecule.

Authors:  Natalia L Varich; Konstantin S Kochergin-Nikitsky; Evgeny V Usachev; Olga V Usacheva; Alexei G Prilipov; Robert G Webster; Nikolai V Kaverin
Journal:  J Gen Virol       Date:  2009-03-18       Impact factor: 3.891

5.  Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage.

Authors:  Carolien E van de Sandt; YingYing Dou; Stella E Vogelzang-van Trierum; Kim B Westgeest; Mark R Pronk; Albert D M E Osterhaus; Ron A M Fouchier; Guus F Rimmelzwaan; Marine L B Hillaire
Journal:  J Gen Virol       Date:  2015-04-21       Impact factor: 3.891

6.  Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.

Authors:  Rogier Bodewes; Pieter L A Fraaij; Martina M Geelhoed-Mieras; Carel A van Baalen; Harm A W M Tiddens; Annemarie M C van Rossum; Fiona R van der Klis; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

7.  Preemptive priming readily overcomes structure-based mechanisms of virus escape.

Authors:  Sophie A Valkenburg; Stephanie Gras; Carole Guillonneau; Lauren A Hatton; Nicola A Bird; Kelly-Anne Twist; Hanim Halim; David C Jackson; Anthony W Purcell; Stephen J Turner; Peter C Doherty; Jamie Rossjohn; Katherine Kedzierska
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

8.  Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses.

Authors:  Yeping Sun; Jun Liu; Meng Yang; Feng Gao; Jianfang Zhou; Yoshihiro Kitamura; Bin Gao; Po Tien; Yuelong Shu; Aikichi Iwamoto; Zhu Chen; George F Gao
Journal:  J Gen Virol       Date:  2009-12-02       Impact factor: 3.891

9.  H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines.

Authors:  Xing Cheng; Michael Eisenbraun; Qi Xu; Helen Zhou; Deepali Kulkarni; Kanta Subbarao; George Kemble; Hong Jin
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

10.  Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections.

Authors:  Mohammed Alsharifi; Yoichi Furuya; Timothy R Bowden; Mario Lobigs; Aulikki Koskinen; Matthias Regner; Lee Trinidad; David B Boyle; Arno Müllbacher
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.